Redefining severe asthma to high-risk asthma: Analysis of real-world data to investigate patients who are at high risk of exacerbations, worsening of symptoms, and a loss of asthma control over time.

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/105928
• EU PAS number:
  EUPAS105920
• Study ID:
  105928
• Official title and acronym:
  Redefining severe asthma to high-risk asthma: Analysis of real-world data to investigate patients who are at high risk of exacerbations, worsening of symptoms, and a loss of asthma control over time.
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  To investigate patients with asthma to determine what characteristics, co-morbidities, treatments, and other clinical characteristics are associated with higher risk of exacerbations, worsening of symptoms and loss of asthma control.
• Study status:
  Planned

Research institutions and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 31/07/2023

Study start date

Planned: 31/07/2023

Data analysis start date

Planned: 14/08/2023

Date of final study report

Planned: 06/11/2023

Sources of funding

Other

More details on funding

OPRI

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable